Ju Chen Selected Research

Ju Chen Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 08/2009
20	Cardiomyopathies (Cardiomyopathy) 01/2022 - 03/2002
13	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 03/2002
11	Heart Failure 01/2020 - 03/2002
8	Muscular Diseases (Myopathy) 05/2024 - 11/2007
8	Heart Diseases (Heart Disease) 01/2023 - 04/2010
7	Inflammation (Inflammations) 02/2023 - 01/2007
5	Carcinogenesis 01/2022 - 04/2010
5	Hypertrophy 10/2015 - 01/2004
5	Fibrosis (Cirrhosis) 11/2014 - 03/2002
5	Cardiomegaly (Heart Hypertrophy) 12/2013 - 01/2006
4	Infections 02/2023 - 12/2013
4	Body Weight (Weight, Body) 10/2016 - 01/2006
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2024 - 01/2004
3	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2002
3	Cardiac Arrhythmias (Arrythmia) 01/2020 - 02/2013
3	Vascular Remodeling 01/2020 - 05/2012
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 03/2012
3	Congenital Heart Defects (Congenital Heart Defect) 01/2018 - 04/2014
3	Neoplasm Metastasis (Metastasis) 05/2016 - 05/2007
3	Insulin Resistance 01/2015 - 01/2009
2	Infarction (Infarctions) 10/2023 - 01/2018
2	Hyperglycemia 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 05/2012
2	Esophageal Squamous Cell Carcinoma 01/2020 - 01/2014
2	Diabetes Mellitus 01/2020 - 01/2015
2	Hypoxia (Hypoxemia) 01/2020 - 07/2008
2	Vascular System Injuries 01/2020 - 11/2016
2	Neointima 01/2020 - 11/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 05/2007
2	Reperfusion Injury 12/2018 - 12/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2017
2	Wounds and Injuries (Trauma) 01/2017 - 01/2016
2	Ganglion Cysts (Ganglion) 04/2016 - 08/2007
2	Glucose Intolerance 01/2015 - 01/2009
1	Distal Myopathies (Distal Muscular Dystrophy) 05/2024
1	Fever (Fevers) 09/2023
1	Common Cold 09/2023
1	Alzheimer Disease (Alzheimer's Disease) 02/2023
1	Neuroinflammatory Diseases 02/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Cardiotoxicity 01/2023
1	Heart Rupture 01/2023

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2002
5	CytokinesIBA 02/2023 - 02/2013
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 08/2009
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2002
5	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 03/2012
5	Transcription Factors (Transcription Factor)IBA 01/2018 - 04/2014
5	Protein Isoforms (Isoforms)IBA 11/2016 - 11/2007
5	CalciumIBA 09/2015 - 01/2004
4	MicroRNAs (MicroRNA)IBA 09/2021 - 03/2015
3	Myosins (Myosin)IBA 05/2024 - 04/2012
3	Interleukin-17 (Interleukin 17)IBA 01/2024 - 11/2019
3	IntegrinsIBA 01/2023 - 03/2002
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2023 - 05/2009
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
3	neurofilament protein LIBA 02/2016 - 03/2012
3	CalcineurinIBA 10/2015 - 05/2011
3	DystrophinIBA 10/2015 - 01/2007
2	Messenger RNA (mRNA)IBA 03/2024 - 01/2024
2	thiazolyl blueIBA 04/2023 - 01/2023
2	erythromycin propionate-N-acetylcysteinateIBA 01/2023 - 11/2016
2	FilaminsIBA 01/2023 - 01/2022
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2020 - 05/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2019
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020 - 05/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 01/2009
2	Circular RNAIBA 01/2020 - 10/2017
2	Leucine (L-Leucine)FDA Link 01/2019 - 03/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 05/2016
2	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 11/2016 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 02/2016 - 09/2014
2	cysteine and glycine-rich protein 3IBA 01/2016 - 10/2015
2	Cytoskeletal ProteinsIBA 10/2015 - 02/2009
2	Peptide Hydrolases (Proteases)FDA Link 12/2013 - 01/2007
2	Protein Kinase CIBA 05/2011 - 02/2004
2	beta CateninIBA 04/2010 - 08/2008
2	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2008 - 01/2006
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 05/2024
1	MYK-461IBA 05/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2024
1	CyclinsIBA 03/2024
1	Interleukin-12 (IL 12)IBA 01/2024
1	Immunologic Factors (Immunomodulators)IBA 01/2024
1	E2F Transcription FactorsIBA 10/2023
1	binafuxiIBA 09/2023
1	AnthracyclinesIBA 01/2023
1	atrophin-1IBA 01/2022
1	IronIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022

Therapy/Procedure

6	Therapeutics 01/2024 - 01/2014
5	Drug Therapy (Chemotherapy) 12/2022 - 03/2012
2	Immunotherapy 01/2024 - 11/2019
2	Radiotherapy 12/2022 - 01/2018
2	Ligation 01/2020 - 11/2016
1	Immunomodulation 01/2024
1	Appendectomy 12/2022